Vlad Ratziu, MD, PhD - Bridging Disciplines to Advance Care in MASH: Exploring GLP-1 RAs for Obesity-Related Liver Disease

Ticiana Leal, MD / Neal Ready, MD, PhD - From Cases to Care: Personalizing First-Line Immunotherapy in Advanced NSCLC Through a Patient-Centered Approach

Christine Franzese, MD / Eileen Wang, MD, MPH - From Case to Clinic: Personalizing the Use of Biologics in CRSwNP Care Plans

Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes

Tina Q. Tan, MD / Litjen (L.J) Tan, MS, PhD - Empowering Patients, Strengthening Immunity: Strategies to Increase Influenza Vaccination Across All Age Groups

Priya Vakharia, MD - The Long View in Neovascular Age-Related Macular Degeneration: Practical Insights on Long-Acting Anti-VEGF Treatment

Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction

Jesus Berdeja, MD - Chartering New Frontiers in Myeloma Care: What Role May Novel CELMoDs Play in Early-Relapse Therapy?

April W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2

Daniel Petrylak, MD - Answering Key Questions About Biomarkers in Urothelial Cancer: Guidance for Improving Implementation

Fernando Jose Martinez, MD, MS, Justin Oldham, MD, MS - Advancing Patient-Centered ILD Care: Post-Congress Insights on Antifibrotics, Treatment Innovations, and Multidisciplinary Approaches

Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World

John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors

Neil D. Gross, MD, FACS - Evolving the Multi-Modal Approach for Resectable Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Assessment of Current and Emerging Immunotherapeutic Strategies

Hussein Tawbi, MD, PhD - Evolving Melanoma Care: The Clinical Impact of Anti-LAG-3/PD-1 Combinations

Evan S. Dellon, MD, MPH - Stepping Up the Management of Eosinophilic Esophagitis: Answering Key Questions on Diagnosis and Use of Pharmacotherapies

Thomas Powles, MBBS, MRCP, MD / Jonathan E. Rosenberg, MD - Advancing Urothelial Carcinoma Care With Multidisciplinary Strategies for Clinical Management

Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors

James F. Howard Jr., MD - C5 Inhibitors for the Treatment of Generalized Myasthenia Gravis: From Clinical Data to Patient-Centered Strategies

Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice